These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7789651)

  • 21. Islet lysosomal enzyme activities and plasma insulin levels in obese hyperglycemic mice following injection of the lysosomotropic drug suramin.
    Lundquist I
    Diabetes Res; 1985 Jul; 2(4):207-11. PubMed ID: 3936659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exocrine and endocrine pancreatic function in rats treated with alpha-glucosidase inhibitor (acarbose).
    Otsuki M; Sakamoto C; Ohki A; Okabayashi Y; Yuu H; Maeda M; Baba S
    Metabolism; 1983 Aug; 32(8):846-50. PubMed ID: 6191180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of alpha-glucosidase inhibitor on exocrine and endocrine pancreatic function in rats fed a high-carbohydrate diet consisting of sucrose or glucose.
    Otsuki M; Okabayashi Y; Ohki A; Suehiro I; Baba S
    Diabetes Res Clin Pract; 1988 Oct; 5(4):257-63. PubMed ID: 2466625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lysosomal storage of glycogen as a sequel of alpha-glucosidase inhibition by the absorbed deoxynojirimycin derivative emiglitate (BAYo1248). A drug-induced pattern of hepatic glycogen storage mimicking Pompe's disease (glycogenosis type II).
    Lembcke B; Lamberts R; Wöhler J; Creutzfeldt W
    Res Exp Med (Berl); 1991; 191(6):389-404. PubMed ID: 1775731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential changes in islet lysosomal enzyme activities in aging obese hyperglycemic mice.
    Lundquist I
    Diabetes Res; 1986 Jan; 3(1):25-30. PubMed ID: 3082567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholinergic muscarinic effects on insulin release in mice.
    Lundquist I
    Pharmacology; 1982; 25(6):338-47. PubMed ID: 6818565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of nitric oxide modulators on cholinergically stimulated hormone release from mouse islets.
    Aring;kesson B; Lundquist I
    J Physiol; 1999 Mar; 515 ( Pt 2)(Pt 2):463-73. PubMed ID: 10050013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Islet constitutive nitric oxide synthase: biochemical determination and regulatory function.
    Salehi A; Carlberg M; Henningson R; Lundquist I
    Am J Physiol; 1996 Jun; 270(6 Pt 1):C1634-41. PubMed ID: 8764145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of ghrelin on insulin and glucagon secretion: a study of isolated pancreatic islets and intact mice.
    Salehi A; Dornonville de la Cour C; Håkanson R; Lundquist I
    Regul Pept; 2004 May; 118(3):143-50. PubMed ID: 15003830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of adrenergic and cholinergic stimulation on islet monoamine oxidase activity and insulin secretion in the mouse.
    Panagiotidis G; Stenström A; Lundquist I
    Eur J Pharmacol; 1993 Mar; 233(2-3):285-90. PubMed ID: 8096820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pattern of islet lysosomal enzyme activities and insulin secretory response.
    Lundquist I; Lövdahl R
    Enzyme; 1977; 22(6):385-90. PubMed ID: 338299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical determination of islet lysosomal enzyme activities following crinophagy-stimulating treatment with diazoxide in mice.
    Skoglund G; Ahrén B; Lundquist I
    Diabetes Res; 1987 Oct; 6(2):81-4. PubMed ID: 3322635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of nitric oxide synthase inhibition, nitric oxide and hydroperoxide on insulin release induced by various secretagogues.
    Panagiotidis G; Akesson B; Rydell EL; Lundquist I
    Br J Pharmacol; 1995 Jan; 114(2):289-96. PubMed ID: 7533613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wortmannin inhibits insulin secretion in pancreatic islets and beta-TC3 cells independent of its inhibition of phosphatidylinositol 3-kinase.
    Gao Z; Konrad RJ; Collins H; Matschinsky FM; Rothenberg PL; Wolf BA
    Diabetes; 1996 Jul; 45(7):854-62. PubMed ID: 8666133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of the islet nitric oxide system with L-arginine-induced secretion of insulin and glucagon in mice.
    Akesson B; Mosén H; Panagiotidis G; Lundquist I
    Br J Pharmacol; 1996 Oct; 119(4):758-64. PubMed ID: 8904652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets.
    Lau T; Carlsson PO; Leung PS
    Diabetologia; 2004 Feb; 47(2):240-8. PubMed ID: 14722647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acarbose is a competitive inhibitor of mammalian lysosomal acid alpha-D-glucosidases.
    Calder PC; Geddes R
    Carbohydr Res; 1989 Aug; 191(1):71-8. PubMed ID: 2776140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective modification of pyruvate dehydrogenase kinase isoform expression in rat pancreatic islets elicited by starvation and activation of peroxisome proliferator-activated receptor-alpha: implications for glucose-stimulated insulin secretion.
    Sugden MC; Bulmer K; Augustine D; Holness MJ
    Diabetes; 2001 Dec; 50(12):2729-36. PubMed ID: 11723055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The constitutive secretory pathway is a major route for islet amyloid polypeptide secretion in neonatal but not adult rat islet cells.
    Verchere CB; D'Alessio DA; Prigeon RL; Hull RL; Kahn SE
    Diabetes; 2000 Sep; 49(9):1477-84. PubMed ID: 10969831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of type-selective phosphodiesterase inhibitors on glucose-induced insulin secretion and islet phosphodiesterase activity.
    Shafiee-Nick R; Pyne NJ; Furman BL
    Br J Pharmacol; 1995 Aug; 115(8):1486-92. PubMed ID: 8564209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.